Comments
U.S. FDA panel backs Sanofi, Isis drug for rare disorder
19.10.2012. | WASHINGTON (Reuters) - A U.S. Food and Drug Administration panel of outside experts recommended the Sanofi SA and Isis Pharmaceutical Inc drug, Kynamro, for treatment of a rare genetic disorder that causes unusually high cholesterol and life-threatening cardiovascular disease....
